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The Prooxidant State and
Psychologic Stress
We have read with interest the work by
Lesgards et al. (1) on the effect of different
lifestyle factors on their test system, which mea-
sures the resistance of red blood cells to an
oxidative challenge. Their study showed that
psychologic stress is a major factor influencing
antioxidant status. This finding encouraged us
to share our experiences of a earlier study that
resulted in similar conclusions using an
enzyme, 5´-ectonucleotidase (NT), located on
the external surface of lymphocytes (2,3). NT is
significant because it has a role in lymphocyte
maturation; newborns with persistently low
activities have multiple infections, whereas with
normalization of NT, their infections resolved
(4). We previously showed that NT activities
decreased, by then-unknown mechanism(s), as
the course of HIV (human immunodeficiency
virus) infection progressed (5). Later, we carried
out this study in psychologically stressed
patients to see if stress itself could lower the
activity of this enzyme and thereby contribute
to the immune deficiency reported for stressed/
depressed patients (6). In one aspect of this
study, honors students in psychology were
monitored at different times of the year when
their stress levels were low (after holidays) and
high (exams/thesis writing). These students
were psychologically assessed for stress using
the Profile of Mood Score (POMS). The
POMS scores were significantly correlated with
NT, which was significantly lower (30%) at
high stress periods and normalized when the
stress resolved (after holidays), indicating the
reversibility of the effect of stress on NT.
In another group of chronically stressed/
depressed patients, NT values were also found
to be very low; however, in a subgroup of these
patients taking vitamins A, C, and E and coen-
zyme Q10, the NT values were equivalent to
those of an unstressed healthy population (2).
Subsequent in vitro studies showed that NT
was inhibited within 5 min after exposure to
superoxide anions and that this effect could be
reversed either by ascorbate added to the in
vitro system at physiologic levels present in
serum (100 µM) or by oral administration of
the same antioxidant mix to volunteers for
about 6 weeks (3,7). Measurement of tissue
ascorbate also showed that this metabolite, like
NT, decreased significantly at high-stress peri-
ods and resolved when the stress dissipated.
Our earlier findings of low NT in HIV-positive
patients further confirmed our oxidant mecha-
nism when these patients were later shown to
have a high prooxidant state (8).
Besides stress, we also studied another
prooxidant state—diabetes—and showed that
with poor management of this condition, as
measured by hemoglobin A1C (HbA1C), NT
decreased significantly (7). That is, NT corre-
lated negatively and significantly with HbA1C.
These studies, taken together, confirmed that
NT is a good indicator of a high prooxidant
state, whether through HIV infection, psycho-
logic stress, or diabetes. 
In summary, psychologic stress gives rise
to a prooxidant state that is reflected by low
NT and increased red blood cell sensitivity to
oxidative insult. Why stress should cause a
prooxidant state is not known. We hypothe-
size that stress by increasing cortisol favors the
development of an innate immune response
(2,3). In normal circumstances the innate
response would abate as the adaptive immune
system takes over. However, with chronic
stress the high prooxidant nature of the innate
response persists, because of chronically ele-
vated cortisol, and NT and probably other
important extracellular proteins of lympho-
cytes are inhibited, resulting in an attenuated
adaptive immune response and subsequent
immunodeficiency. That an innate or pro-
inflammatory process persists in stressed
patients is evidenced by persistent increased
blood concentrations of acute phase proteins
seen in these patients (9,10). 
Ainsley H. Chalmers
Flinders University of South Australia
Bedford Park, South Australia
E-mail: chalmers.ah@flinders.edu.au
Jane S. Blake-Mortimer
University of Adelaide
Adelaide, South Australia
Anthony H. Winefield
University of South Australia
Adelaide, South Australia
REFERENCES AND NOTES
1. Lesgards J-F, Durand P, Lassarre M, Stocker P, Lesgards
G, Lanteaume A, Prost M, Lehucher-Michel M-P.
Assessment of lifestyle effects on the overall antioxidant
capacity of healthy subjects. Environ Health Perspect
110:479–486 (2002).
2. Blake-Mortimer JS, Winefield AH, Chalmers AH. The rela-
tionship between 5´-ectonucleotidase and psychological
stress. Int J Stress Manage 3:189–207 (1996).
3. Blake-Mortimer JS, Winefield AH, Chalmers AH.
Evidence for free radical-mediated reduction of lympho-
cytic 5´-ectonucleotidase during stress. Int J Stress
Manage 5:57–75 (1998).
4. Bastian JF, Ruedi JM, MacPherson GA, Golembsky HE,
O’Connor RD, Thompson LF. Lymphocyte ecto-5´-nucleoti-
dase activity in infancy: increasing activity in peripheral
blood B cells precedes their ability to synthesize IgG in
vitro. J Immunol 132:1767–1772 (1984).
5. Chalmers AH, Hare C, Wooley G, Frazier IH. Lymphocyte
ectoenzyme activity compared in healthy persons and
patients seropositive to or at high risk of HIV infection.
Immunol Cell Biol 68:81–85 (1990).
6. Cohen S, Miller GE, Rabin BS. Psychological stress and
antibody response to immunization: a critical review of
the human literature. Psychosom Med 63:7–18 (2001).
7. Chalmers AH, Blake-Mortimer JS, Winefield AH.
Lymphocytic 5’-ectonucleotidase, an indicator of oxida-
tive stress in humans. Redox Report 5:89–91 (2000).
8. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S.
Oxidative stress and plasma antioxidant micronutrients in
humans with HIV infection. Am J Clin Nutr. 67:143–147
(1998).
9. Maes M. A review on the acute phase response in major
depression. Rev Neurosci 4:407–416 (1993).
10. Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA,
Boswell DR. Elevated levels of acute phase plasma pro-
teins in major depression. Biol Psychiatry 32:1035–1041
(1992).
The Prooxidant State and
Psychologic Stress: Response
to Chalmers et al.
We thank Chalmers et al. for their interest in
our paper published in EHP (1). We also thank
them for sharing their earlier studies on free
radical-mediated reduction of lymphocytic 5´-
ectonucleotidase (NT) activity during psycho-
logic stress (2–4) and on the reduction of this
activity during HIV infection and diabetes
(4,5), which were reported to be associated
with a high prooxidant state.
Their works have actually shown that psy-
chologic stress results in a decreased NT activity
and in a decreased tissue ascorbate that can both
be normalized by antioxidant intake or when
the stress resolved. Thereby, Chalmers et al. sug-
gest that psychologic stress itself can cause an
increased prooxidant state responsible for
decreased NT activity, which may contribute to
the immune deficiency reported in stressed or
depressed patients. They thus propose that a
decrease in NT activity may be a good marker
of a prooxidant state in humans (2–4).
In agreement with their hypothesis, our
population-based study underlined that, inde-
pendently of other studied factors and in par-
ticular of tobacco smoking, psychologic stress
truly contributes to a decrease in the overall
antioxidant capacity of healthy subjects as
measured by means of the free radical-medi-
ated hemolysis test (Spiral’s KRL test) (6,7).
Furthermore, our results indicated that among
the studied factors and besides cigarette smok-
ing, psychologic stress was the lifestyle factor
that was most markedly associated with a
decreased antioxidant capacity (1). Thus, in
accordance with reports from Chalmers et al.
(5), Niki (8) and Young and Woodside (9)
suggest that psychologic stress can induce per
se an unbalanced antioxidative homeostasis
leading to the occurrence of oxidant stress that
may increase the incidence of free radical-
mediated diseases such as cancer, cardiovascu-
lar diseases, diabetes, inflammatory diseases,
and HIV infection.
It is noteworthy that the aim of our study
was to evaluate lifestyle factors that may con-
tribute to the normal variability of the overall
antioxidant status in healthy subjects. Because
of the involvement of numerous studied
lifestyle factors in the variability of the overall
antioxidant status evaluated in our study, we
did not thoroughly discuss oxidant stress prob-
ably caused by psychologic stress or emphasize
the major importance of the potential involve-
ment of psychologic stress in human disease.
Although we have not previously mentioned
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stress-mediated prooxidant state, we hope that
these letters will highlight their studies.
Concerning the mechanism underlying
psychologic stress-related oxidant stress
described by Chalmers et al., we agree with
their hypothesis of the involvement of a
chronic elevation of cortisol favoring the devel-
opment of an innate immune response at the
expense of the humoral immune system, which
results in chronic inflammatory process and
therefore in a high prooxidant state. Whether
the inhibition of cortisol action as compared
to antioxidant therapy could reduce the
prooxidant state induced by psychologic stress
remains to be determined. Moreover, accord-
ing to Chalmers et al. (4), lymphocytic NT
activity appears to be a good marker of oxi-
dant stress. Additional clinical designs are now
needed to confirm the use of this assay as a
biomarker of a prooxidant state. The use of
the hemolysis test in combination with ana-
lytic dosages of specific biomarkers of antioxi-
dant and prooxidant states could be helpful
for this purpose.
In conclusion, in light of Chalmers and co-
workers’ findings (3,4) and of our own findings
(1), psychologic stress effects, which are often
underestimated, should be taken into account
among healthy control subjects and among
patients bearing free radical-mediated disease in
clinical and epidemiologic trials. In particular,
regarding Chalmers et al.’s study that showed a
reduced NT activity probably related to oxi-
dant stress during HIV infection (5), it should
be determined whether psychologic stress is
responsible for an oxidant stress-mediated
increase in immune deficiency resulting from
HIV infection. Indeed, investigations on the
potential involvement of psychologic stress in
human free radical-mediated and degenerative
disease are still too scarce, and Chalmers et al.
are right in emphasizing the major potential
influence of psychologic stress.
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Neuropsychologic Testing 
versus Visual Contrast
Sensitivity in Diagnosing PEAS
I would like to comment on Hudnell and
Shoemaker’s response (Hudnell and Shoemaker
2002) to our letter (Swinker and Burke 2002),
both published in the March 2002 issue of
EHP.
In their letter Hudnell and Shoemaker
(2002) asserted that “neuropsychologic test
deficits are nonspecific.” In the hands of
trained neuropsychologists, specific areas of
functional deficits can be identified.
Attention, executive function, short-term
memory, mood, adjustment, and verbal or
visual fluency can be specifically assessed.
Convergent validity can be established by
evaluating functioning in a number of ways,
that is, different test instruments that measure
the same thing. Neuropsychologic deficits of a
specific nature with characteristic patterns
have been found in response to certain envi-
ronmental exposures. The use of neuropsy-
chologic testing has been validated in a variety
of clinical settings and is not in dispute.
Memory problems have been the most
unique and significant symptoms reported fol-
lowing Pfiesteria exposure in both the labora-
tory setting (Glasgow et al. 1995) and in the
1997 Maryland environmental cohort
(Grattan et al. 1998). This memory deficit was
objectified and quantified in Maryland by use
of neuropsychologic testing. Significant abnor-
malities were observed on three specific tests;
the Rey Auditory Verbal Learning Test was the
most consistently and significantly affected.
Other tests batteries, which measured other
neuropsychologic functions, were not affected
in the same way. Therefore, the Maryland
neuropsychologic findings were specific. The
deficits were not global. Their subjects’ 
complaints did correlate with the specific test
performance observed.
Use of visual contrast sensitivity (VCS)
testing in lieu of neuropsychologic testing in
the context of possible estuary associated syn-
drome (PEAS) is very much in dispute.
Shoemaker and Hudnell (2001) offer no evi-
dence to support their assertion that VCS can
be used in place of neuropsychologic testing in
the evaluation of PEAS. Until the VCS test is
validated in direct comparison to the neuro-
psychologic testing that has been demon-
strated to be sensitive to PEAS, advocacy of
the test remains in the realm of speculation. 
Other authors have echoed our reserva-
tions about the use of VCS over the past year.
According to Rubin et al. (2001), 
VCS testing is controversial because abnormal
findings are not toxin-specific and abnormal
findings can be interpreted only cautiously
unless accompanied by other fairly extensive
visual tests.
Morris (2001) also commented that
Data supporting use of the test in this setting
are weak. Visual contrast sensitivity is affected
by underlying eye disorders, including corneal
and lens disorders (i.e., the effect on the contrast
sensitivity function is optical), as well as retinal
and optic nerve disorders. As the individuals
most likely to experience possible Pfiesteria toxin
exposure are those individuals spending signifi-
cant amounts of time on the water, there is a
heightened probability of ultraviolet exposure-
associated eye disease, such as lenticular opacity
and age-related macular degeneration. Thus, a
positive screening test for impaired contrast sen-
sitivity may simply reflect the environmental/
occupational context for the tested individual.
There is clearly a need for further research in
this area.
Whether all the hotline callers in our 1997
study (Swinker et al. 2001) are considered
exposed or unexposed depends on whether the
estuary associated syndrome criteria for 1997
[Centers for Disease Control and Prevention
(CDC) 1997] or the more liberal criteria from
1999 (CDC 1999) are used. Since PEAS is
the current appellation and the one that
Hudnell and Shoemaker discuss (Shoemaker
and Hudnell 2001), then all the hotline callers
should remain grouped together because they
are all “exposed” under the PEAS criteria. The
current PEAS case description includes the
stipulation that “a health care provider cannot
identify another cause for the symptoms”
(CDC 1999). This type of analysis was
included in our work as an accepted—and
expected—research practice. [A similar
process of analysis was also done in the origi-
nal Maryland work, where cases were defined
based on documented exposure to estuary
waters and abnormal performance on neu-
ropsychologic testing that could not be
explained otherwise (Grattan et al. 1998).]
Our hotline callers with neuropsychologic test
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Correspondenceimpairment had a variety of well-accepted
medical explanations for their symptoms or
test performances; there was no need or justi-
fication to postulate a new syndrome (Swinker
et al. 2001). They had no unique or consistent
pattern of abnormality on the Rey Auditory
Verbal Learning Test or any other test battery.
Their performance was affected across a vari-
ety of functional areas, not in a single area.
The neuropsychologic test performances of
the callers as a group and of their asympto-
matic controls were similar (Swinker et al.
2001). Thus we have not “dismissed the diag-
noses of estuary-associated syndrome”
(Hudnell and Shoemaker 2002). We have
subjected the data to scientific analysis before
forming our conclusions.
Hudnell’s VCS data (Hudnell and
Shoemaker 2002) suggest that the perfor-
mance of the hotline control group (10 per-
sons without symptoms) in our original work
(Swinker et al. 2001) was also abnormal. This
finding suggests that VCS deficits may be
highly prevalent and so nonspecific as to be of
limited value as a diagnostic test. VCS is
affected by many factors: chemical exposures
(e.g., mercury or solvents), congenital condi-
tions (e.g., dyslexia or other learning disabili-
ties), degenerative conditions (e.g., Parkinson’s
disease and multiple sclerosis), ocular disease
(e.g., glaucoma or macular degeneration),
other conditions [e.g., AIDS or cystic fibrosis
(Hudnell 1998)], and the use of alcohol or
medications (e.g., antiepilepsy drugs).
Assessment of hydrogen sulfide exposure
in estuary fishermen was included in a multi-
year longitudinal cohort study recently con-
ducted in North Carolina (Moe et al. 2001).
VCS and neuropsychologic testing were also
systematically performed at regular intervals as
part of this investigation. The data analysis
phase of this effort has just begun. We should
soon know more about the frequency of
hydrogen sulfide exposure in estuary watermen
as well as any relationship or correlation
between VCS and neuropsychologic test per-
formance in watermen over the seasons and
the years.
Finally, subsequent to the CDC report
(CDC 2000) quoted in my letter (Swinker
and Burke 2002), the state of Maryland has
verified five PEAS cases in their ongoing sur-
veillance, as noted by Hudnell and Shoemaker
(2002). These cases have been reported to the
CDC (Backer et al. 2001) with little fanfare
and detailing some methodologic concerns
regarding exposure assessment. I do not know
whether any of Hudnell and Shoemaker’s
cases are included in those five cases.
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Neuropsychologic Testing 
versus Visual Contrast
Sensitivity: Response
We appreciate the opportunity to respond to
Swinker’s letter regarding our response
(Hudnell and Shoemaker 2002) to her previous
letter (Swinker and Burke 2002). Her previous
letter concerned our first EHP article
(Shoemaker and Hudnell 2001) on possible
estuary-associated syndrome (PEAS). Her cur-
rent letter raises five issues: a) “nonspecificity” of
visual contrast sensitivity (VCS) and neuropsy-
chologic tests; b) memory loss being the most
unique and significant effect in PEAS; c) validity
of VCS as an indicator of neurologic deficits in
PEAS cases; d) VCS deficits in Swinker’s 10
hotline caller controls; and e) hydrogen sulfide
exposure in North Carolina estuaries.
Concerning “nonspecific” tests, in their
previous letter Swinker and Burke (2002)
objected to our use of VCS tests in PEAS inves-
tigations because VCS deficits are “nonspe-
cific.” As noted in our EHP articles on PEAS
(Shoemaker 2001; Shoemaker and Hudnell
2001) and in our response to her first letter
(Hudnell and Shoemaker 2002), VCS deficits
are “nonspecific” because they have multiple
possible etiologies. In her current letter Swinker
objects to our response that “neuropsychologic
test deficits are nonspecific,” reasoning that
neuropsychologic tests identify “specific areas of
functional deficits.” We maintain that tests
which detect functional deficits associated with
impairment in specific neurologic pathways are
still “nonspecific” tests if there is more than one
possible etiologic agent. Our position is consis-
tent with the definition of “nonspecific” in
Dorland’s Illustrated Medical Dictionary
(Dorland 1988): “1. not due to any single
known cause, as to a particular pathogen.” We
stand by our statement and maintain that both
VCS and neuropsychologic tests a) are “non-
specific” because deficits have multiple possible
causes; b) can reveal impairment in specific
neurologic pathways; c) are useful objective
indicators of neurologic impairment in a syn-
drome otherwise described only by “nonspe-
cific” symptoms and; d) require investigation of
alternative explanations of deficits because the
tests are “nonspecific.”
Swinker stated that 
Memory problems have been the most unique
and significant symptoms reported following
Pfiesteria exposure in both the laboratory setting
(Glasgow et al. 1995) and in the 1997 Maryland
environmental cohort (Grattan et al. 1998) 
This statement is not supported by those
reports or the experience of clinicians who have
recognized PEAS cases. Memory problems are
not unique to PEAS, and cases reported many
symptoms, each of which can cause a signifi-
cant decline in quality of life. The laboratory
worker most severely affected by Pfiesteria
exposure reported 13 multiple-system symp-
toms (Glasgow et al. 1995). He recovered
memory function over many months, but
developed unilateral blindness for which
Pfiesteria exposure was considered the most
likely cause (Schmechel and Koltai 2001). The
Maryland study reported higher percentages of
10 symptoms in exposed participants than in
control participants (Grattan et al. 1998).
Memory loss was not a unique symptom cate-
gory in that study, but was lumped with confu-
sion, disorientation, and concentration
difficulty (Grattan et al. 1998). Shoemaker’s 37
PEAS cases reported 18 diverse symptoms, 13
of which were reported by more than one-
third of the cases, and VCS was reduced by
60% in cases relative to controls (Shoemaker
2001). In her current letter, Swinker further
states that the Maryland neuropsychologic
results were specific for memory loss and that
“deficits were not global.” The Maryland study
actually reported statistically significant neu-
ropsychologic deficits in fine motor speed, dex-
terity, resistence to interference, and selective
attention in addition to memory loss (Grattan
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is a distinct syndrome characterized by multi-
ple-system symptoms and a variety of neuro-
logic effects, including vision and memory loss.
Swinker states that VCS has not been vali-
dated for use in helping to diagnose PEAS. We
submit that many steps have been taken toward
validation. Impetus for investigating the valid-
ity of VCS in PEAS diagnosis came from earlier
observations of VCS deficits in populations
contacting Pfiesteria-inhabited estuaries, relative
to populations without exposure potential
(Hudnell 1998; Hudnell et al. 2001; Turf et al.
1999). The group differences in VCS were
independent of age, smoking, and bright sun-
light exposure, and the groups did not appear
to differ in exposures to solvents, pesticides,
metals, or fumes. The absence of group differ-
ences in visual acuity suggested that neuro-
logic, rather than optical, factors likely caused
the VCS deficits. The data further indicated
that the VCS deficits were related to total time
spent at fish kills in the past. These results sug-
gested that the VCS deficit might be a persis-
tent sign of a neurologic effect from Pfiesteria
toxin(s) or other factors associated with estuar-
ine contact (Hudnell 1998; Hudnell et al.
2001; Swinker et al. 2001a). Our subsequent
EHP articles reported the initial data on valid-
ity of VCS as an indicator of neurologic
impairment in cases meeting the Centers for
Disease Control and Prevention (CDC) crite-
ria for PEAS (Shoemaker 2001; Shoemaker
and Hudnell 2001). The Grand Rounds cases
(Shoemaker and Hudnell 2001) showed large
VCS deficits during illness, and VCS recovery
coincident with symptom resolution after
cholestyramine treatment during acute,
chronic, and repeated-acquisition of PEAS.
These associations between VCS, symptoms,
and treatment were verified in Shoemaker’s
subsequent cohort study and double-blinded,
placebo-controlled crossover trial (Shoemaker
2001). Control conditions ruled out several
possible causes of VCS fluctuations; VCS
remained stable over time in healthy individu-
als, VCS was not altered by cholestyramine
therapy in hypercholesterolemia patients who
did not have PEAS, and PEAS cases showed
VCS recovery and symptom resolution with
cholestyramine, but not placebo, therapy
(Shoemaker 2001). The VCS deficits in PEAS
cases did not appear to be caused by solvent
exposures. The group average VCS spatial-fre-
quency profile in the PEAS cases (Shoemaker
2001) showed greatest reduction at midspatial
frequency, similar to that seen following
chronic solvent exposure (Hudnell 1998).
Solvent exposure cases, however, did not
respond to cholestyramine therapy (Shoemaker
RC. Unpublished data), and review of the 
literature revealed no reports of therapy that
were effective at resolving solvent-induced
VCS deficits. Ocular abnormalities and dis-
eases involving neurologic function also were
probably not the cause of VCS deficits in the
PEAS cases. None of  Shoemaker’s active
PEAS cases received treatment for these condi-
tions during the time of cholestyramine ther-
apy and VCS recovery (Shoemaker 2001;
Shoemaker and Hudnell 2001). Each of these
observations is an important step in the process
of validating VCS for use in PEAS diagnosis.
Further validation may come from the demon-
stration of correlations between VCS and neu-
ropsychologic data during illness and recovery
with treatment in 17 of Shoemaker’s PEAS
cases who submitted to neuropsychologic test-
ing (Shoemaker RC. Unpublished data).
In her letter, Swinker claims that VCS
deficits in the hotline controls suggest “that
VCS deficits may be highly prevalent and so
nonspecific as to be of limited value as a diag-
nostic test.” Her 10 local government-
employee controls all reported exposure to
Pfiesteria-inhabited estuaries and/or organic sol-
vents, risk factors for VCS deficits (Hudnell
and Shoemaker 2002). Although Swinker
claims that the controls were “asymptomatic”
in her current letter, neither her report
(Swinker et al. 2001b) nor our review of the
original data (Hudnell HK. Unpublished data)
indicated that symptoms were assessed in the
control group. Swinker’s speculation on the
prevalence of VCS deficits based on a small
sample with confounding factors and incom-
plete assessment is unfounded. The consistent
ability of studies to show VCS differences
between exposed and control cohorts suggests
that VCS deficits are not common in control
populations screened for risk factors such as
neurotoxic exposure and neurologic disease
(Hudnell et al. 1996).
Finally, Swinker proposed that hydrogen
sulfide exposure in estuarine waters may cause
VCS deficits (Swinker and Burke 2002) and
implied that this hypothesis would be assessed
in the North Carolina longitudinal cohort
study. The North Carolina study did not
include measurements of hydrogen sulfide or
any other potentially neurotoxic compound
(Moe et al. 2001). Questions on odor detec-
tion were included but are not sufficient to
address the hypothesis. Hydrogen sulfide expo-
sures at concentrations and durations that may
impact VCS are unlikely to be encountered in
the open estuaries frequented by watermen. 
We look forward to additional clarification
of these issues in peer-reviewed research articles.
This letter was reviewed by the National
Health and Environmental Effects Research
Laboratory, U.S. Environmental Protection Agency,
and approved for publication. Approval does not sig-
nify that the contents necessarily reflect the views
and policies of the agency, nor does mention of trade
names or commercial products constitute endorse-
ment or recommendation.
H. Kenneth Hudnell
U.S. Environmental Protection Agency
ORD/NHEERL/NTD/NPBT
Research Triangle Park, North Carolina
E-mail: hudnell.ken@epamail.epa.gov
Ritchie C. Shoemaker
Center for Research on Biotoxin-Associated
Illness, Inc.
Pocomoke City, Maryland
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